4 research outputs found

    Selected maternal characteristics at randomization and child characteristics among 730 children born to women who participated in a trial of 400 mg/d docosahexaenoic acid during pregnancy and had measures of infant development at 18 mo of age, by intervention group<sup>a</sup>.

    No full text
    <p>Abbreviations: IUGR—Intra uterine growth retardation: birth weight for gestational age <10th.</p><p><sup>a</sup> Values are Mean (Standard Deviation) unless otherwise indicated</p><p><sup>b</sup> T-test for comparison of means and chi-square test for comparison of proportions percentile Williams reference</p><p>Selected maternal characteristics at randomization and child characteristics among 730 children born to women who participated in a trial of 400 mg/d docosahexaenoic acid during pregnancy and had measures of infant development at 18 mo of age, by intervention group<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0120065#t001fn002" target="_blank"><sup>a</sup></a>.</p

    Comparison of measures of infant development using the Bayley Scales of Infant Development II (BSID II) at age 18 mo among 730 children born to women who participated in a trial of maternal supplementation with 400 mg/d docosahexaenoic acid during pregnancy, by treatment group<sup>a</sup>.

    No full text
    <p><sup>a</sup>Values are Mean (SD) unless otherwise indicated.</p><p><sup>b</sup>unadjusted difference (DHA-placebo).</p><p><sup>c</sup> Difference (DHA-placebo) adjusted for maternal height, child sex, and child age at measurement.</p><p>Comparison of measures of infant development using the Bayley Scales of Infant Development II (BSID II) at age 18 mo among 730 children born to women who participated in a trial of maternal supplementation with 400 mg/d docosahexaenoic acid during pregnancy, by treatment group<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0120065#t002fn001" target="_blank"><sup>a</sup></a>.</p
    corecore